On March 12, 2019 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) reported that company executives are scheduled to participate in the following upcoming investor conferences (Press release, Ligand, MAR 12, 2019, View Source [SID1234534274]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Barclays Global Healthcare Conference in Miami. Presentation takes place on Wednesday, March 13, 2019 at 9:00 a.m. Eastern time (6:00 a.m. Pacific time). John Higgins, CEO will attend for Ligand.
31st Annual Roth Conference in Laguna Niguel, California. Presentation takes place on Monday, March 18, 2019 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time). Matt Foehr, COO and Matt Korenberg, CFO will attend for Ligand.
H.C. Wainwright Global Life Sciences Conference in London. Conference takes place on Tuesday, April 9, 2019. John Higgins, CEO will attend for Ligand.
16th Annual Craig-Hallum Institutional Investor Conference in Minneapolis. Conference takes place on Wednesday, May 29, 2019 with one-on-one meetings only. John Higgins, CEO, Matt Foehr, COO and Matt Korenberg, CFO will attend for Ligand.
A live webcast of the Barclays and Roth conference presentations will be available on Ligand’s website at www.ligand.com. A replay of the presentations will be archived on the website for 30 days.